FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167826970> ?p ?o ?g. }

• W2167826970 endingPage "997" @default.
• W2167826970 startingPage "989" @default.
• W2167826970 abstract "Background INCB018424 is a novel, potent Janus kinase (JAK)1/JAK2 inhibitor that blocks signal transduction of multiple proinflammatory cytokines. Objectives To evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of topical INCB018424 phosphate cream in patients with plaque psoriasis. Methods Topical INCB018424 phosphate 1·0% or 1·5% cream was applied once daily (QD) or twice daily (BID) for 4 weeks to 2–20% body surface area in five sequential cohorts of five patients aged 18–65 years. Target lesions were scored on a scale of 0–4 for erythema, scaling and thickness. Additionally, the overall disease activity in each patient was measured using Physician's Global Assessment. INCB018424 concentrations were measured in plasma, and cytokine stimulated phosphorylated signal transducer and activator of transcription 3 phosphorylation (pSTAT3) levels in peripheral blood cells were evaluated. Pretreatment and post-treatment skin biopsies were compared with healthy skin, including evaluation of histopathology, immunohistochemistry and mRNA expression. Results Treatment with INCB018424 phosphate cream either 1·0% QD or 1·5% BID resulted in improvements in lesion scores. No significant inhibition of pSTAT3 in peripheral blood cells was observed following topical application, consistent with the generally low steady-state plasma concentrations of INCB018424 measured. Transcriptional markers of immune cell lineage/activation in lesional skin were reduced by topical INCB018424, with correlations observed between clinical improvement and decreases in markers of T helper 17 lymphocyte activation, dendritic-cell activation and epidermal hyperplasia. INCB018424 treatment reduced epidermal hyperplasia and dermal inflammation in most patient samples, with reductions in CD3, CD11c, Ki67 and keratin 16 observed by immunohistochemical analysis. Conclusions Topical INCB018424 dosed for 28 days QD or BID is pharmacologically active in patients with active psoriasis and modulates proinflammatory cytokines in the pathogenesis of psoriatic lesions." @default.
• W2167826970 created "2016-06-24" @default.
• W2167826970 creator A5005999476 @default.
• W2167826970 creator A5015366048 @default.
• W2167826970 creator A5015740195 @default.
• W2167826970 creator A5018193992 @default.
• W2167826970 creator A5020509979 @default.
• W2167826970 creator A5026747005 @default.
• W2167826970 creator A5027146475 @default.
• W2167826970 creator A5032370825 @default.
• W2167826970 creator A5032817666 @default.
• W2167826970 creator A5041230347 @default.
• W2167826970 creator A5041528983 @default.
• W2167826970 creator A5046355139 @default.
• W2167826970 creator A5049859852 @default.
• W2167826970 creator A5049901206 @default.
• W2167826970 creator A5054787908 @default.
• W2167826970 creator A5059677466 @default.
• W2167826970 creator A5066047781 @default.
• W2167826970 date "2015-10-01" @default.
• W2167826970 modified "2023-10-03" @default.
• W2167826970 title "Downmodulation of key inflammatory cell markers with a topical Janus kinase 1/2 inhibitor" @default.
• W2167826970 cites W1967493670 @default.
• W2167826970 cites W1971708477 @default.
• W2167826970 cites W2000851235 @default.
• W2167826970 cites W2012077729 @default.
• W2167826970 cites W2013488106 @default.
• W2167826970 cites W2023733075 @default.
• W2167826970 cites W2035817785 @default.
• W2167826970 cites W2045163297 @default.
• W2167826970 cites W2075375417 @default.
• W2167826970 cites W2078226469 @default.
• W2167826970 cites W2091238378 @default.
• W2167826970 cites W2125212735 @default.
• W2167826970 cites W2135299099 @default.
• W2167826970 cites W2145684092 @default.
• W2167826970 cites W2163712919 @default.
• W2167826970 cites W4233561050 @default.
• W2167826970 doi "https://doi.org/10.1111/bjd.13994" @default.
• W2167826970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26123031" @default.
• W2167826970 hasPublicationYear "2015" @default.
• W2167826970 type Work @default.
• W2167826970 sameAs 2167826970 @default.
• W2167826970 citedByCount "53" @default.
• W2167826970 countsByYear W21678269702015 @default.
• W2167826970 countsByYear W21678269702016 @default.
• W2167826970 countsByYear W21678269702017 @default.
• W2167826970 countsByYear W21678269702018 @default.
• W2167826970 countsByYear W21678269702019 @default.
• W2167826970 countsByYear W21678269702020 @default.
• W2167826970 countsByYear W21678269702021 @default.
• W2167826970 countsByYear W21678269702022 @default.
• W2167826970 countsByYear W21678269702023 @default.
• W2167826970 crossrefType "journal-article" @default.
• W2167826970 hasAuthorship W2167826970A5005999476 @default.
• W2167826970 hasAuthorship W2167826970A5015366048 @default.
• W2167826970 hasAuthorship W2167826970A5015740195 @default.
• W2167826970 hasAuthorship W2167826970A5018193992 @default.
• W2167826970 hasAuthorship W2167826970A5020509979 @default.
• W2167826970 hasAuthorship W2167826970A5026747005 @default.
• W2167826970 hasAuthorship W2167826970A5027146475 @default.
• W2167826970 hasAuthorship W2167826970A5032370825 @default.
• W2167826970 hasAuthorship W2167826970A5032817666 @default.
• W2167826970 hasAuthorship W2167826970A5041230347 @default.
• W2167826970 hasAuthorship W2167826970A5041528983 @default.
• W2167826970 hasAuthorship W2167826970A5046355139 @default.
• W2167826970 hasAuthorship W2167826970A5049859852 @default.
• W2167826970 hasAuthorship W2167826970A5049901206 @default.
• W2167826970 hasAuthorship W2167826970A5054787908 @default.
• W2167826970 hasAuthorship W2167826970A5059677466 @default.
• W2167826970 hasAuthorship W2167826970A5066047781 @default.
• W2167826970 hasConcept C112392421 @default.
• W2167826970 hasConcept C126322002 @default.
• W2167826970 hasConcept C142724271 @default.
• W2167826970 hasConcept C164027704 @default.
• W2167826970 hasConcept C197934379 @default.
• W2167826970 hasConcept C203014093 @default.
• W2167826970 hasConcept C2776914184 @default.
• W2167826970 hasConcept C2778375690 @default.
• W2167826970 hasConcept C2778690821 @default.
• W2167826970 hasConcept C2779121184 @default.
• W2167826970 hasConcept C71924100 @default.
• W2167826970 hasConcept C98274493 @default.
• W2167826970 hasConceptScore W2167826970C112392421 @default.
• W2167826970 hasConceptScore W2167826970C126322002 @default.
• W2167826970 hasConceptScore W2167826970C142724271 @default.
• W2167826970 hasConceptScore W2167826970C164027704 @default.
• W2167826970 hasConceptScore W2167826970C197934379 @default.
• W2167826970 hasConceptScore W2167826970C203014093 @default.
• W2167826970 hasConceptScore W2167826970C2776914184 @default.
• W2167826970 hasConceptScore W2167826970C2778375690 @default.
• W2167826970 hasConceptScore W2167826970C2778690821 @default.
• W2167826970 hasConceptScore W2167826970C2779121184 @default.
• W2167826970 hasConceptScore W2167826970C71924100 @default.
• W2167826970 hasConceptScore W2167826970C98274493 @default.
• W2167826970 hasIssue "4" @default.
• W2167826970 hasLocation W21678269701 @default.
• W2167826970 hasLocation W21678269702 @default.

• next